309
Participants
Start Date
February 2, 2017
Primary Completion Date
November 27, 2024
Study Completion Date
November 30, 2029
177Lu-edotreotide PRRT
PRRT using 177Lu-edotreotide will be performed 3-monthly. A maximum of four cycles will be administered.
Everolimus
Everolimus will be administered as a standard dosis of 10 mg daily which may be reduced where required for acceptable tolerability.
Amino-Acid Solution
The Amino-Acid Solution (AAS) to be used in this study will contain a mixture of 25 g lysine and 25 g arginine diluted in 2000 mL of electrolyte solution, infused over 4 - 6 h, starting 30 - 60 min before PRRT
Institut Jules Bordet, Brussels
Allgemeines Krankenhaus Wien, Vienna
Royal North Shore Hospital, Saint Leonards
Peter MacCallum Cancer Centre, Melbourne
Universitaire Ziekenhuizen Leuven, Leuven
Inselspital, Universitätsspital Bern, Bern
Olivia Newton-John Cancer & Wellness Centre, Austin Hospital, Heidelberg
Universitätsspital Basel, Basel
Fiona Stanley Hospital, Murdoch
University Cape Town (UCT), Groote Schuur Hospital, Cape Town
UniversitätsSpital Zürich, Zurich
Charité - Universitätsmedizin Berlin, Berlin
Fondazione IRCCS Istituto Nazionale dei Tumori, Milan
European Institute of Oncology (EIO), Milan
University Medical Center, Abteilung für Nuklearmedizin, Hamburg
MD Anderson Cancer Center Madrid, Madrid
University Hospital 12 de Octubre, Madrid
IUCT-Oncopole, Toulouse
Central University Hospital de Asturias (HUCA), Oviedo
Moffitt Cancer Center & Research Institute, Tampa
Institut de Recherche en Cancérologie de Montpellier (IRCM), Montpellier
Philipps Universität Marburg, Marburg
Universitätsklinikum Magdeburg A.ö.R., Otto-von-Guericke Universität, Magdeburg
CHU de Nantes - Hôtel Dieu, Nantes
Universitätsklinikum Essen, Essen
University and Polytechnic Hospital La Fe, Valencia
Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) Srl, Meldola
University of Michigan Comprehensive Cancer Center, Ann Arbor
Universitätsklinikum Bonn, Bonn
Northwestern Memorial Hospital, Chicago
Centre Jean Perrin, Clermont-Ferrand
Hospices civils de Lyon, Bron
Excel Diagnostics & Nuclear Oncology Center, Houston
Klinikum rechts der Isar Technische Universität München, Munich
Banner Health d.b.a. Banner MD Anderson Cancer Center, Gilbert
Universitätsklinikum Ulm, Ulm
Universitätsklinikum Erlangen, Erlangen
HP Hôpital Beaujon, Clichy
Stanford University, Stanford
Universitätsklinikum Würzburg, Würzburg
Zentralklinik Bad Berka GmbH, Bad Berka
University Hospital Olomouc, Olomouc
University Hospital Motol, Prague
Academic Medical Center, University of Amsterdam, Amsterdam
MSC Memorial Cancer Centre, Gliwice
"Gammed Izabela Chuchrowksa", Warsaw
University of Pretoria & Steve Biko Academic Hospital, Pretoria
Vall d'Hebron University Hospital, Barcelona
ICO Hospitalet, Granvia de l'Hospitalet, Barcelona
Royal Free NHS Foundation Trust, London
Kings College Hospital, London
The Christie NHS Foundation Trust, Manchester